Stalevo 75 Tablet – (75mg+18.75mg+200mg)

Stalevo 75 Tablet is a combination medication used in the treatment of Parkinson’s disease. It contains three active ingredients: Levodopa, Carbidopa, and Entacapone. This formulation is designed to help manage the symptoms of Parkinson’s disease by increasing the levels of dopamine in the brain, which is typically deficient in individuals with the condition. Stalevo 75 provides a more comprehensive approach to treatment by combining these three drugs, addressing multiple pathways involved in the disease.

Key Features:

• Purpose: Stalevo 75 Tablet is used to treat Parkinson’s disease and its symptoms, particularly in patients who experience motor fluctuations (like on-off episodes) while on Levodopa therapy. It works by improving dopamine levels in the brain, which helps control the motor symptoms of Parkinson’s disease, such as tremors, stiffness, and bradykinesia (slowness of movement).
• Key Benefits:
  • Combination Formula: This tablet combines Levodopa, Carbidopa, and Entacapone, providing a more effective and convenient treatment for Parkinson’s disease.
  • Levodopa (75mg): Levodopa is the main precursor for dopamine, helping increase dopamine levels in the brain, which improves motor control.
  • Carbidopa (18.75mg): Carbidopa prevents the breakdown of Levodopa before it reaches the brain, ensuring more Levodopa is available for conversion into dopamine.
  • Entacapone (200mg): Entacapone inhibits catechol-O-methyltransferase (COMT), an enzyme that breaks down dopamine and Levodopa, thereby increasing their availability and extending their effect.
  • Improved Symptom Control: The combination of these three agents allows for longer-lasting control of symptoms and reduced “off” periods (times when the medication is less effective).
• Key Ingredients:
  • Levodopa (75mg): The primary agent for increasing dopamine levels.
  • Carbidopa (18.75mg): Helps prevent the peripheral breakdown of Levodopa.
  • Entacapone (200mg): Prolongs the effects of Levodopa and dopamine by inhibiting its breakdown.
• Usage: The Stalevo 75 Tablet is typically taken orally with food to reduce stomach upset. The dosage and frequency depend on the individual patient’s condition, severity of symptoms, and response to the medication. Dosage adjustments may be needed based on the patient’s clinical response.
• Packaging: Stalevo 75 Tablets are usually packaged in blister packs or bottles, with each tablet containing 75mg of Levodopa, 18.75mg of Carbidopa, and 200mg of Entacapone.

Who Is It For?

Stalevo 75 Tablet is prescribed for:

• Patients with Parkinson’s disease, especially those who experience motor fluctuations or insufficient control of symptoms with Levodopa therapy alone.
• People who are already receiving Levodopa and Carbidopa therapy but require additional management to address the breakdown of dopamine.

Side Effects:

Like all medications, Stalevo 75 Tablet may cause side effects. Some common and serious side effects include:

• Nausea and vomiting.
• Dizziness or lightheadedness, especially when standing up quickly (orthostatic hypotension).
• Involuntary movements (dyskinesia).
• Hallucinations or confusion.
• Darkened urine (a known, harmless side effect from Entacapone).
• Severe muscle stiffness or tremors.

If any severe side effects occur, it is essential to contact a healthcare provider immediately.

Summary:

Stalevo 75 Tablet (75mg Levodopa, 18.75mg Carbidopa, 200mg Entacapone) is a combination therapy used to treat Parkinson’s disease by improving dopamine levels in the brain. This medication helps manage the motor symptoms of Parkinson’s disease, particularly in patients experiencing fluctuating motor responses. The combination of Levodopa, Carbidopa, and Entacapone allows for better control of symptoms and longer-lasting effects than when using Levodopa alone.